Literature DB >> 17451187

Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis.

Y Hori1, Y Oda, K Kiyoshima, Y Yamada, Y Nakashima, S Naito, M Tsuneyoshi.   

Abstract

Renal cell carcinoma (RCC) is more frequently observed in patients on dialysis than in patients with normal renal function. However, the mechanism underlying carcinogenesis in RCC patients on dialysis is still unclear. We hypothesized that oxidative stress affects patients on dialysis and generates new neoplasms, and therefore analysed the correlation between the influences of various markers of oxidative stress and carcinogenesis in those patients. We evaluated the immunohistochemical expression of oxidative stress markers, such as iNOS, 8-OHdG, and COX-2 in 42 cases on dialysis and 51 cases with normal renal function as a control. The methylation status of p16INK4a, p14ARF, VHL, and RASSF1A was analysed together with clinicopathological factors. Histologically, the papillary type was observed more frequently in dialysis RCC than in sporadic RCC. Immunohistochemically, overexpression of iNOS (p < 0.0001) and COX-2 (p = 0.0002) was more frequently observed in dialysis RCC. Furthermore, the 8-OHdG labelling index was significantly higher in dialysis RCC than in sporadic RCC. Hypermethylation of p16INK4a was more frequently found in dialysis RCC (p < 0.05). However, no significant correlations between oxidative stress markers and DNA hypermethylation status were observed. The overexpression of iNOS, COX-2, and 8-OHdG in dialysis RCC suggests that patients on dialysis are affected by oxidative stress and that this effect plays an important role in the genesis of dialysis RCC. Copyright 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451187     DOI: 10.1002/path.2176

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis.

Authors:  Yanlin Yu; Xu Guan; Ling Nie; Yong Liu; Ting He; Jiachuan Xiong; Xinli Xu; Yan Li; Ke Yang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Mol Med (Berl)       Date:  2017-05-15       Impact factor: 4.599

3.  Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.

Authors:  Alberto Breda; Giuseppe Lucarelli; Giuseppe Luccarelli; Oscar Rodriguez-Faba; Luis Guirado; Carmen Facundo; Carlo Bettocchi; Loreto Gesualdo; Giuseppe Castellano; Giuseppe Grandaliano; Michele Battaglia; Juan Palou; Pasquale Ditonno; Humberto Villavicencio
Journal:  World J Urol       Date:  2014-02-07       Impact factor: 4.226

4.  The incidence of urinary tract cancers is related to preserved diuresis: a single-center report.

Authors:  Vedran Premuzic; Marija Gamulin; Marijana Coric; Bojan Jelakovic
Journal:  Int Urol Nephrol       Date:  2017-10-16       Impact factor: 2.370

5.  VPAC1 overexpression is associated with poor differentiation in colon cancer.

Authors:  Shaohua Liu; Yunjie Zeng; Yunhua Li; Wenying Guo; Jiali Liu; Nengtai Ouyang
Journal:  Tumour Biol       Date:  2014-03-28

6.  Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.

Authors:  Fumiyoshi Fushimi; Kenichi Taguchi; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Mayumi Ono; Yutaka Nakashima; Tetsuro Takesue; Seiji Naito; Yoshinao Oda
Journal:  Virchows Arch       Date:  2013-08-02       Impact factor: 4.064

7.  Glutamine with probiotics attenuates intestinal inflammation and oxidative stress in a rat burn injury model through altered iNOS gene aberrant methylation.

Authors:  Zhen-Yu Gong; Zhi-Qiang Yuan; Zhi-Wei Dong; Yi-Zhi Peng
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

8.  DNA methylation of oxidative stress genes and cancer risk in the Normative Aging Study.

Authors:  Tao Gao; Brian Thomas Joyce; Lei Liu; Yinan Zheng; Qi Dai; Zhou Zhang; Wei Zhang; Martha J Shrubsole; Meng-Hua Tao; Joel Schwartz; Andrea Baccarelli; Lifang Hou
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 9.  Molecular targets on the horizon for kidney and urothelial cancer.

Authors:  Joaquim Bellmunt; Bin T Teh; Giampaolo Tortora; Jonathan E Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2013-08-27       Impact factor: 66.675

10.  MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis.

Authors:  Nengtai Ouyang; Caihua Zhu; Dingying Zhou; Ting Nie; Mae F Go; Robert J Richards; Basil Rigas
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.